Literature DB >> 18332229

Unprecedented diversity of genotypic revertants in lymphocytes of a patient with Wiskott-Aldrich syndrome.

Brian R Davis1, Michael J Dicola, Nicole L Prokopishyn, Jonathan B Rosenberg, Daniele Moratto, Linda M Muul, Fabio Candotti, R Michael Blaese.   

Abstract

Spontaneous somatic reversions of inherited mutations are poorly understood phenomena that are thought to occur uncommonly in a variety of genetic disorders. When molecularly characterized, revertant cells have rarely exhibited more than one revertant genotype per patient. We analyzed individual allospecific T-cell clones derived from a Wiskott-Aldrich syndrome (WAS) patient identified by flow cytometry to have 10% to 15% revertant, WAS protein-expressing lymphocytes in his blood. Genotypic analysis of the clones revealed a remarkable diversity of deletions and base substitutions resulting in at least 34 different revertant genotypes that restored expression of WASp. A large fraction of these revertant genotypes were also identified in primary T cells purified from peripheral blood. These data suggest that the use of sensitive methods may reveal the presence of wide arrays of individual genotypic revertants in WAS patients and offer opportunities for further understanding of their occurrence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18332229      PMCID: PMC2384133          DOI: 10.1182/blood-2007-06-095299

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype.

Authors:  Q Zhu; C Watanabe; T Liu; D Hollenbaugh; R M Blaese; S B Kanner; A Aruffo; H D Ochs
Journal:  Blood       Date:  1997-10-01       Impact factor: 22.113

2.  Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells.

Authors:  V Stephan; V Wahn; F Le Deist; U Dirksen; B Broker; I Müller-Fleckenstein; G Horneff; H Schroten; A Fischer; G de Saint Basile
Journal:  N Engl J Med       Date:  1996-11-21       Impact factor: 91.245

3.  Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones.

Authors:  H Yssel; J E De Vries; M Koken; W Van Blitterswijk; H Spits
Journal:  J Immunol Methods       Date:  1984-08-03       Impact factor: 2.303

4.  Somatic revertant mosaicism in a patient with leukocyte adhesion deficiency type 1.

Authors:  Yumi Tone; Taizo Wada; Fumie Shibata; Tomoko Toma; Yoko Hashida; Yoshihito Kasahara; Shoichi Koizumi; Akihiro Yachie
Journal:  Blood       Date:  2007-02-01       Impact factor: 22.113

5.  Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome.

Authors:  T Ariga; T Kondoh; K Yamaguchi; M Yamada; S Sasaki; D L Nelson; H Ikeda; K Kobayashi; H Moriuchi; Y Sakiyama
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

6.  Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency.

Authors:  R Hirschhorn; D R Yang; J M Puck; M L Huie; C K Jiang; L E Kurlandsky
Journal:  Nat Genet       Date:  1996-07       Impact factor: 38.330

7.  Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings.

Authors:  Taizo Wada; Akihiro Konno; Shepherd H Schurman; Elizabeth K Garabedian; Stacie M Anderson; Martha Kirby; David L Nelson; Fabio Candotti
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 8.  In vivo reversion to normal of inherited mutations in humans.

Authors:  R Hirschhorn
Journal:  J Med Genet       Date:  2003-10       Impact factor: 6.318

9.  Multiple patients with revertant mosaicism in a single Wiskott-Aldrich syndrome family.

Authors:  Taizo Wada; Shepherd H Schurman; G Jayashree Jagadeesh; Elizabeth K Garabedian; David L Nelson; Fabio Candotti
Journal:  Blood       Date:  2004-05-13       Impact factor: 22.113

Review 10.  WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype.

Authors:  Kohsuke Imai; Shigeaki Nonoyama; Hans D Ochs
Journal:  Curr Opin Allergy Clin Immunol       Date:  2003-12
View more
  12 in total

Review 1.  Revertant mosaicism in skin: natural gene therapy.

Authors:  Joey E Lai-Cheong; John A McGrath; Jouni Uitto
Journal:  Trends Mol Med       Date:  2010-12-29       Impact factor: 11.951

2.  Mutations to the rescue.

Authors:  Mike May
Journal:  Nat Med       Date:  2011-04       Impact factor: 53.440

Review 3.  Ethical considerations in genomic testing for hematologic disorders.

Authors:  Jonathan M Marron; Steven Joffe
Journal:  Blood       Date:  2017-06-09       Impact factor: 22.113

Review 4.  WASP: a key immunological multitasker.

Authors:  Adrian J Thrasher; Siobhan O Burns
Journal:  Nat Rev Immunol       Date:  2010-03       Impact factor: 53.106

5.  Intrathymic adeno-associated virus gene transfer rapidly restores thymic function and long-term persistence of gene-corrected T cells.

Authors:  Marie Pouzolles; Alice Machado; Mickaël Guilbaud; Magali Irla; Sarah Gailhac; Pierre Barennes; Daniela Cesana; Andrea Calabria; Fabrizio Benedicenti; Arnauld Sergé; Indu Raman; Quan-Zhen Li; Eugenio Montini; David Klatzmann; Oumeya Adjali; Naomi Taylor; Valérie S Zimmermann
Journal:  J Allergy Clin Immunol       Date:  2019-09-09       Impact factor: 10.793

6.  Revertant somatic mosaicism in the Wiskott-Aldrich syndrome.

Authors:  Brian R Davis; Fabio Candotti
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

Review 7.  Somatic genetic rescue in Mendelian haematopoietic diseases.

Authors:  Patrick Revy; Caroline Kannengiesser; Alain Fischer
Journal:  Nat Rev Genet       Date:  2019-06-11       Impact factor: 53.242

Review 8.  Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.

Authors:  Fabio Candotti
Journal:  J Clin Immunol       Date:  2017-10-30       Impact factor: 8.542

9.  Gene Correction of iPSCs from a Wiskott-Aldrich Syndrome Patient Normalizes the Lymphoid Developmental and Functional Defects.

Authors:  Tamara J Laskowski; Yasmine Van Caeneghem; Rasoul Pourebrahim; Chao Ma; Zhenya Ni; Zita Garate; Ana M Crane; Xuan Shirley Li; Wei Liao; Manuel Gonzalez-Garay; Jose Carlos Segovia; David E Paschon; Edward J Rebar; Michael C Holmes; Dan Kaufman; Bart Vandekerckhove; Brian R Davis
Journal:  Stem Cell Reports       Date:  2016-07-07       Impact factor: 7.765

10.  Evolution of highly polymorphic T cell populations in siblings with the Wiskott-Aldrich Syndrome.

Authors:  Maxim I Lutskiy; Jun Y Park; Susanna K Remold; Eileen Remold-O'Donnell
Journal:  PLoS One       Date:  2008-10-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.